BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:69b064241575c
DTSTAMP:20260310T183412Z
DTSTART;TZID=Europe/London:20191212T100000
DTEND;TZID=Europe/London:20191212T110000
TZID:Europe/London
SUMMARY:External Seminar: Amoxicillin in combination with imipenem-relebactam to treat Mycobacterium abscessus infection
DESCRIPTION:Speaker- Dr Jonathan Cox    Biography  Dr Jonathan Cox leads the Mycobacterial Research Group at Aston University. His group consists of three PhD students and one post-doctoral researcher, along with a number of master’s and undergraduate students. They are a multidisciplinary team with a diverse skill-set, spanning microbiology, biochemistry, molecular genetics, structural biology and drug discovery. Their main focus is to study the physiology of various pathogenic mycobacteria (such as Mycobacterium abscessus, Mycobacterium tuberculosis and Mycobacterium bovis) and to discover new ways to treat infections. By using the physiology to inform antibiotic drug discovery, they develop new treatment regimens that are able to overcome factors contributing to antibiotic resistance in these highly antibiotic-tolerant bacteria.   https://events.st-andrews.ac.uk/events/external-seminar-amoxicillin-in-combination-with-imipenem-relebactam-to-treat-mycobacterium-abscessus-infection/
LOCATION:Medical Sciences Building, North Haugh, KY16 9TF, St Andrews, Fife, Scotland
URL:https://events.st-andrews.ac.uk/events/external-seminar-amoxicillin-in-combination-with-imipenem-relebactam-to-treat-mycobacterium-abscessus-infection/
End:VEVENT
End:VCALENDAR